Feedback / Questions
atropine low dose (NVK002) - Nevakar
https://www.globenewswire.com/news-release/2025/01/29/3017068/0/en/Vyluma-Announces-Acceptance-of-Drug-Application-for-NVK002-by-China-s-National-Medical-Products-Administration-NMPA.html
Jan 29, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next